Scoring system for optimal cord blood unit selection for single cord blood transplantation

脐带血 川地34 医学 移植 内科学 骨髓 免疫学 人类白细胞抗原 男科 干细胞 胃肠病学 生物 抗原 遗传学
作者
Mizuki Watanabe,Takaaki Konuma,Nobuhiko Imahashi,Seitaro Terakura,Sachiko Seo,Satoko Morishima,Naoyuki Uchida,Noriko Doki,Masatsugu Tanaka,Tetsuya Nishida,Toshiro Kawakita,Tetsuya Eto,Satoshi Takahashi,Masashi Sawa,Yasufumi Uehara,Sung‐Won Kim,Fumihiko Ishimaru,Tatsuo Ichinohe,Takahiro Fukuda,Yoshiko Atsuta
出处
期刊:Cytotherapy [Elsevier]
卷期号:26 (3): 286-298
标识
DOI:10.1016/j.jcyt.2023.12.001
摘要

We conducted a retrospective study to categorize the cord blood unit (CBU)s to identify the optimal units.A total of 8503 adults (female, n = 3592; male, n = 4911) receiving their first single cord blood transplantation (CBT) in 2000-2019 were analyzed. Factors associated with CBUs affecting overall survival (OS) and neutrophil engraftment were selected to create ranked categorization for each outcome, followed by comparison with transplantation using HLA-matched bone marrow (BMT)/peripheral blood stem cell (PBSCT) from unrelated (n = 6052) and related donors (n = 4546).Sex-mismatch, CD34+ cell and CFU-GM counts were selected in the OS analysis. Considering the strong interaction between sex mismatch and CD34+ cell counts, we analyzed females and males separately. For females, female CBU with CD34+ cell counts {greater than or equal to} 0.5 × 10e5/kg and CFU-GM counts {greater than or equal to} 15 × 10e3/kg offered the best OS (Group I), followed by other groups with any (Groups II-IV) or all (Group V) of the risk factors. Group I consistently showed favorable OS (Group IV: HR1.22, P = 0.027; Group V: HR1.31, P = 0.047), comparable to those of rBMT/PBSCT (OS: HR1.02, P = 0.654) and uBM/PBSCT in patients with higher rDRI (HR1.07, P = 0.353). Male patients lacked significant factors affecting OS. Categorization for neutrophil engraftment consisting of CD34+ cell and CFU-GM counts, sex-mismatch, presence of donor-specific antibodies, and the number of HLA-mismatches was effective but not predicted OS.Our ranked categorizations sufficiently predicted female OS and engraftment. The best-ranked CBUs offered preferable outcomes comparable to conventional BM/PB donors in female but not in male patients.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
Ava应助科研通管家采纳,获得10
刚刚
刚刚
完美世界应助Mercury采纳,获得10
刚刚
科研通AI6.1应助pipiap采纳,获得10
刚刚
科研通AI6.1应助pipiap采纳,获得10
刚刚
ppg123应助科研通管家采纳,获得10
1秒前
wcc应助科研通管家采纳,获得30
1秒前
1秒前
丘比特应助科研通管家采纳,获得10
1秒前
ppg123应助科研通管家采纳,获得10
1秒前
niewei应助科研通管家采纳,获得10
1秒前
ppg123应助科研通管家采纳,获得10
1秒前
1秒前
ppg123应助科研通管家采纳,获得10
1秒前
在水一方应助科研通管家采纳,获得10
1秒前
Mic应助科研通管家采纳,获得10
1秒前
研友_VZG7GZ应助科研通管家采纳,获得10
1秒前
ppg123应助科研通管家采纳,获得10
1秒前
ppg123应助科研通管家采纳,获得10
1秒前
上官若男应助科研通管家采纳,获得10
1秒前
1秒前
小马甲应助科研通管家采纳,获得10
1秒前
niewei应助科研通管家采纳,获得10
1秒前
Ava应助科研通管家采纳,获得10
1秒前
1秒前
ppg123应助科研通管家采纳,获得10
1秒前
fanatic应助科研通管家采纳,获得10
1秒前
丘比特应助科研通管家采纳,获得10
1秒前
ppg123应助科研通管家采纳,获得10
2秒前
2秒前
2秒前
2秒前
2秒前
ppg123应助科研通管家采纳,获得10
2秒前
2秒前
2秒前
2秒前
2秒前
Mic应助科研通管家采纳,获得10
2秒前
ppg123应助科研通管家采纳,获得10
2秒前
高分求助中
2025-2031全球及中国金刚石触媒粉行业研究及十五五规划分析报告 40000
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
Introduction to strong mixing conditions volume 1-3 5000
Ägyptische Geschichte der 21.–30. Dynastie 2500
Clinical Microbiology Procedures Handbook, Multi-Volume, 5th Edition 2000
„Semitische Wissenschaften“? 1510
从k到英国情人 1500
热门求助领域 (近24小时)
化学 材料科学 生物 医学 工程类 计算机科学 有机化学 物理 生物化学 纳米技术 复合材料 内科学 化学工程 人工智能 催化作用 遗传学 数学 基因 量子力学 物理化学
热门帖子
关注 科研通微信公众号,转发送积分 5743234
求助须知:如何正确求助?哪些是违规求助? 5413106
关于积分的说明 15347071
捐赠科研通 4884098
什么是DOI,文献DOI怎么找? 2625582
邀请新用户注册赠送积分活动 1574482
关于科研通互助平台的介绍 1531345